Madrigal is eying an expansion of Rezdiffra’s capabilities via combination with precision siRNA gene silencing.

The potentially $4.4 billion deal is Madrigal’s second with a China-based biotech and hands the company six preclinical RNA ...

The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain ...

Dublin-based biotech firm Aerska has raised $39m (€33m) in funding to help it advance development of its technology. Aerska is developing medicines that use RNA interference (RNAi), a ...

Brings total funds raised to $60 million since launch, months after its seed funding announcement in October 2025Appoints Arno de Wilde, Philip ...

Amgen added to uncertainty surrounding the OX40 drug class by returning an autoimmune candidate to Kyowa Kirin. | Amgen added ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment of BBB shuttle–siRNA ...

The American Heart Association released its 2026 Heart Disease and Stroke Statistics Update, and a reminder that heart ...

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

The Fiesta Bowl matchup between No. 6 Mississippi and No. 10 Miami turned into an instant classic, with the Hurricanes coming from behind to win 31-27 and advance to the College Football Playoff ...